ConductScience.org, home

Paper3918946

Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-Gamma.

Schwartz R and 4 others. Int J Cancer, 1985. Cited by 86 papers, by iCite.

Cite this record

ConductScience Library. Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-Gamma. Papers, record 3918946. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3918946

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-Gamma.
PubMed
Journal
Int J Cancer
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
86
iCite
Relative citation ratio, by iCite
2.55
iCite
Revised in PubMed
2019-07-08
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schwartz RR
2Momburg FF
3Moldenhauer GG
4Dörken BB
5Schirrmacher VV

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarcinomaMajor topic
Histocompatibility Antigens Class IIMajor topic
Interferon-gammaMajor topic
Breast Neoplasms
Cell Line
Electrophoresis, Polyacrylamide Gel
Female
Fluorescent Antibody Technique
HLA Antigens
Humans
Immunoenzyme Techniques
Laryngeal Neoplasms
Lung Neoplasms
Uterine Cervical Neoplasms

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.

PMIDTitleJournalYearIn PapersSource
41227306Safety Assessment of Stem Cell-Based Therapies: Current Standards and Advancing Frameworks.Cells2025https://conductscience.org/library/papers/41227306PubMed
31564911Major histocompatibility complex class II molecule in non-small cell lung cancer diagnosis, prognosis and treatment.Onco Targets Ther2019https://conductscience.org/library/papers/31564911PubMed
28315927HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.Cancer Immunol Immunother2017https://conductscience.org/library/papers/28315927PubMed
24563618HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.Neoplasia2014https://conductscience.org/library/papers/24563618PubMed
21572948Establishment of Primary Cultures of Human Biliary Epithelium and Induction of Class II Major Histocompatibility Complex Antigens by Interferon Gamma.Transplant Proc1988https://conductscience.org/library/papers/21572948PubMed
10849555
Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognition but suppresses non-MHC-restricted effector cell activity.
Gene Ther2000https://conductscience.org/library/papers/10849555PubMed
8852397Autologous graft-versus-host disease.Med Oncol1995https://conductscience.org/library/papers/8852397PubMed
8400331Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation.Breast Cancer Res Treat1993https://conductscience.org/library/papers/8400331PubMed
8124687MHC antigen expression by melanomas recovered from mice treated with allogeneic mouse fibroblasts genetically modified for interleukin-2 secretion and the expression of melanoma-associated antigens.Cancer Immunol Immunother1994https://conductscience.org/library/papers/8124687PubMed
7737562Effect of gliadin and other food peptides on expression of MHC class II molecules by HT-29 cells.Gut1995https://conductscience.org/library/papers/7737562PubMed
3722412Lymphocytic infiltration and survival in rectal cancer.J Clin Pathol1986https://conductscience.org/library/papers/3722412PubMed
3569495Interferon-beta can induce the production of plasminogen activator by cultured human cancer cells.Experientia1987https://conductscience.org/library/papers/3569495PubMed
3144087The relationship between epithelial Ia expression and the inflammatory cell infiltrate during experimental oral carcinogenesis.Virchows Arch A Pathol Anat Histopathol1988https://conductscience.org/library/papers/3144087PubMed
2227249Class II (HLA-DR, -DP, and -DO) antigens on intestinal epithelia in ulcerative colitis, Crohn's disease, colorectal cancer and normal small intestine.Gastroenterol Jpn1990https://conductscience.org/library/papers/2227249PubMed
2108803Recombinant human interferon gamma exerts an anti-proliferative effect and modulates the expression of human leukocyte antigens A,B,C and DR in human urothelial cell lines.Cancer Immunol Immunother1990https://conductscience.org/library/papers/2108803PubMed
2100410Rationale for immunotherapy of renal cell carcinoma.Urol Res1990https://conductscience.org/library/papers/2100410PubMed
1711927
Differential growth inhibition and enhancement of major histocompatibility complex class I antigen expression by interferons in a small-cell lung cancer cell line and its doxorubicin-selected multidrug-resistant variant.
Cancer Immunol Immunother1991https://conductscience.org/library/papers/1711927PubMed
1310252Three types of human lung tumour cell lines can be distinguished according to surface expression of endogenous urokinase and their capacity to bind exogenous urokinase.Br J Cancer1992https://conductscience.org/library/papers/1310252PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
MICA100507436PubTator's text mininghttps://conductscience.org/library/genes/100507436NCBI Gene
TFRC7037PubTator's text mininghttps://conductscience.org/library/genes/7037NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3918946

GET https://conductscience.org/api/papers/v1/3918946/authors